The FDA granted emergency authorization to a new treatment for patients with the COVID-19 coronavirus infection this week. The drug is a monoclonal antibody therapy approved for mild to moderate infections in patients over the age of 12. 

But people are having a hard time getting past one part of the experimental medication from Eli Lilly. It’s the name: Bamlanivimab. 

Twitter users had some thoughts: 

Everyone deserves accurate information about COVID-19. Support journalism without a paywall — and keep it free for everyone — by becoming a HuffPost member today.
 
A HuffPost Guide To Coronavirus